Our current study showed that fatty acid degradation, TCA cycle, nicotinate, and nicotinamide metabolism as the major perturbed pathways that could modulate amyloidogenesis in TDP-43-induced ALS. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.